Equities

Arch Therapeutics Inc

ARTH:QBB

Arch Therapeutics Inc

Actions
  • Price (USD)0.282
  • Today's Change0.000 / 0.00%
  • Shares traded46.00
  • 1 Year change-78.31%
  • Beta3.4821
Data delayed at least 15 minutes, as of Nov 13 2024 17:08 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Arch Therapeutics, Inc. is a biotechnology company developing and marketing products based on its AC5 self-assembling technology platform. These products can be advances in the field of stasis and barrier applications. The Company’s flagship products and product candidates are derived from its AC5 self-assembling peptide (SAP) technology platform and referred to as AC5 or the AC5 Devices. These include AC5 Advanced Wound System and AC5 Topical Hemostat, which are intended for skin applications, such as management of complicated chronic wounds and acute surgical wounds. Other products are in development for use in minimally invasive or open surgical procedures and include AC5-GTM for gastrointestinal endoscopic procedures and AC5-V and AC5 Surgical Hemostat for hemostasis inside the body. It is developing BioSurgery products for internal use, including for hemostasis and sealant applications, and gastrointestinal endoscopic surgical procedures.

  • Revenue in USD (TTM)148.17k
  • Net income in USD-12.99m
  • Incorporated2009
  • Employees8.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Sonendo Inc37.46m-47.49m677.24k216.00--0.033--0.0181-100.33-88.7279.0449.070.4981.956.91173,421.30-63.14---78.26--35.04---126.79--1.73-8.540.5194--5.30---6.78------
Dynatronics Corp32.53m-3.43m870.67k111.00--0.1031--0.0268-0.7237-0.72376.862.671.163.839.08293,098.80-9.63-7.48-13.37-10.0723.4725.81-8.29-5.980.6442-5.440.2139---19.89-12.2639.47--1.66--
Nano Mobile Healthcare Inc0.00-5.46m982.13k3.00---------0.2255-0.22550.00-0.01290.00----0.00-10,475.82-----------------0.3173----------------
Remedent Inc1.13m-259.38k999.80k16.00--0.2112--0.8857-0.013-0.0130.05650.23670.14743.452.69---3.247.35-5.2012.9365.3864.60-21.9721.200.2033-0.7720.00---33.63-21.70-140.31------
LogicMark Inc9.74m-15.46m1.08m26.00--0.0406--0.1112-8.62-8.625.215.370.49933.87687.63374,625.80-72.96-28.39-78.79-33.1866.9367.24-146.12-63.552.36--0.00---16.67-10.32-117.56--37.76--
Escalon Medical Corp11.98m-176.93k1.11m40.00--0.9551--0.0928-0.0239-0.02391.620.2442.384.276.34299,537.80-2.49-1.31-5.51-2.8842.9543.60-1.05-0.64431.04-5.030.1457---1.634.47-179.87--12.74--
Catheter Precision Inc436.00k-9.49m1.22m14.00--0.023--2.80-12.95-12.950.604618.900.01410.55743.8931,142.86-30.71---33.63--92.20---2,176.84--0.098--0.0434--3,057.14---165.67------
Arch Therapeutics Inc148.17k-12.99m1.25m8.00------8.46-3.69-3.690.0383-2.830.100.0662--18,521.25-828.03-188.28---804.6339.58---8,276.08-26,945.920.0051-1.32----383.83---32.35---21.76--
Hawkeye Systems Inc0.00-578.72k1.37m44.00---------0.093-0.0930.00-0.30060.00-------117.01-314.04-----------195.39---1.49--------52.81------
Telesis Bio Inc16.28m-50.12m1.62m137.00------0.0993-29.66-30.689.615.610.19473.153.40118,832.10-57.15---64.21--49.47---293.54--1.72-52.960.356--0.2697---1.14------
Acutus Medical Inc12.16m-5.82m1.64m233.00------0.1347-0.19650.69660.413-0.16390.17911.321.4452,184.55-8.58-46.76-11.07-56.88-13.40-89.12-47.89-773.491.88-3.391.18--136.3627.03-141.35---35.99--
SINTX Technologies Inc3.13m-8.60m1.77m43.00--0.2005--0.5666-271.52-271.5216.4411.820.18181.777.6372,697.67-50.01-45.71-62.67-57.3667.7258.47-275.14-681.801.79--0.0265--68.2994.2449.75--54.10--
Helius Medical Technologies Inc594.00k-8.84m1.77m22.00--0.2797--2.98-10.68-10.680.50421.980.06060.74864.4827,000.00-90.17-98.37-110.33-143.5712.7937.27-1,487.54-1,580.663.80--0.00---18.176.1437.11---41.95--
Data as of Nov 13 2024. Currency figures normalised to Arch Therapeutics Inc's reporting currency: US Dollar USD

Institutional shareholders

6.75%Per cent of shares held by top holders
HolderShares% Held
Cavalry Fund I Management LLCas of 18 Jul 2023300.00k6.75%
Data from 10 Sep 2024 - 10 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.